Document:

Termination of the supply agreement

 Exhibit 4.17 
 This Agreement is made on the 27th day of September 2006 between 
 Philips Electronics Hong Kong
Limited, Philips Semiconductors Competence Centre HK (“Philips”) 
 And 
 PSi Technologies, Inc., also acting on behalf its affiliated companies (“PSI”) 
 WHEREAS Pursuant to a meeting held in Hong Kong on 27th day September 2006, 
 Philips and PSi have reached a final settlement in relation to the termination of the supply agreement made between Electronics Devices Limited, Philips Electronics UK Ltd. And PSi Technologies, Inc. 14th January 2004 (“Supply Agreement”). 
 NOW, the parties agree as follows: 
  

	 1.
	 With effect from 27th September 2006 (“Termination Date”), the Supply Agreement is terminated. 

  

	2.	Both Parties refer to the attached Total Cost Summary as shown in Annex A and both parties agree to settle all outstanding obligations and liabilities detailed thereto.

  

	3.	Each party agrees to release the other party from all obligations and liabilities which may arise under any terms and conditions contained in the Supply Agreement, and all the
rights created thereunder shall also be terminated at the same time. 

  

	4.	Details regarding the termination of the Supply Agreement will be defined and agreed upon between the parties in a separate document. Each party hereby releases the other from all
obligations liabilities and claims whatsoever which it has against the other party for or by reason or in respect of any terms and conditions under the Supply Agreement. In this regard, neither party shall not raise any further claims or otherwise
against the other party. 

  

	5.	The governing law and jurisdiction of this Agreement shall be the same as those set out in the Supply Agreement. 

  

									
	 Philips Electronics Hong Kong Limited
 Philips Semiconductors Competence Centre HK
	 		 	PSi Technologies, Inc.
					
	By:	 	/s/    THEO HALDERS        	 		 	By:	 	/s/    GORDON J.
STEVENSON        
	Name:	 	Theo Halders	 		 	Name:	 	Gordon J. Stevenson
	Title:	 	VP & GM	 		 	Title:	 	COO

 Annex A 
  

	9.	Total Cost Summary (2006-09-27 Meeting) 

  

					
	 (1)    Leadframe & Other Materials
	  	US$	31   	 
	 (2)    Equipment Spare Parts
	  	US$	341K	*
	 (3)    Low Grade & Excess Unit
	  	US$	 10K	 
	 (4)    Equipment Restoration
	  	 	(US$7.6K	)
	 (5)    PSPI Material Purchase Support
	  	 	(US$478K	)
	 (6)    PSI-CD Subcon Cost
	  	US$	 103.4K	 
		  	 	 	 
	          Total
	  	US$	0K	 

 Remarks: PSI will return all Philips equipment and spare parts to Philips HK. 
 In relation to the post termination arrangement of the supply agreement, the parties agree that: 
  

	1.	PSi shall within reasonable period from the Termination Date, return all the consigned equipment and all spare parts to such location as designated by Philips.

  

	2.	Philips shall use it reasonable effort in assisting PSi in identifying alternative applications for the excess materials.Employment Agreement dated April 1, 2007 with W. Robert Doll.

 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of this 1st day of April, 2007, by and between Robert Doll (the “Executive”), an individual, and Cryo-Cell International, Inc.
(the “Company”), a Delaware corporation having its principal place of business at 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, Florida 34677. 
 In consideration of the mutual covenants and agreements contained herein and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 
  

	1.	Employment 

 On the terms and conditions set
forth in this Agreement, the Company hereby employs the Executive for a period of twelve (12) months commencing on April 1, 2007, and expiring on March 31, 2008, (the “Initial Term”). The Initial Term shall be automatically
extended for successive additional one-year periods (“Additional Employment Terms”) unless, at least sixty (60) days prior to the end of the Initial Term or an Additional Employment Term the Company or the Executive has notified the
other in writing (“Termination Notice”) that the Agreement shall terminate at the end of the then current term. References herein to the “Term” shall mean the Initial Term as it may be so extended by one or more Additional
Employment Terms. 
 The Executive shall be employed as Vice President of Marketing and Sales & Service. The Executive shall report
directly to the Company’s Chief Executive Officer. 
 The Executive hereby accepts such employment and agrees to devote his full
business time, energy and efforts to the performance of services for the Company. The Executive agrees that during the Term, he shall devote his professional knowledge and experience and provide his best effort, skill and abilities in the
performance of his duties under this Agreement and in the furtherance of the interests of the businesses of the Company and its affiliates. 
  

	2.	Compensation 

 During the Term, and as full
compensation for all of the Executive’s services rendered under this Agreement, the Executive shall receive the following compensation and benefits: 
  

	 	a.	Base Salary 

 Commencing on April 1, 2007 the
Executive shall receive an annualized base salary (the “Base Salary”) which is not less than $198,000.00 per year. Throughout the Term, the Executive shall be eligible for discretionary annual merit increases and/or other base salary
adjustments as deemed appropriate by the Company’s Chief 

 
Executive Officer. The Executive’s Base Salary will be payable in equivalent bi-weekly installments, subject to usual and required payroll deductions,
including, without limitation, applicable taxes. 
  

	 	b.	Annual Bonus 

 Throughout the Term, the Executive shall be eligible for discretionary annual lump-sum incentive awards available for senior executive officers based upon both personal and corporate performance for the prior fiscal
year. The annual bonus, if awarded, will be distributed on or about February 1st of each year of this Agreement
based on performance for the previous fiscal year. The annual bonus is not guaranteed and its amount is subject to the discretion of the Compensation Committee. 
  

	 	c.	Long-Term Incentive Awards 

 Throughout the Term,
the Executive shall be eligible for long-term incentive (“LTI”) award programs extended to senior executive officers generally at levels commensurate with the Executive’s position. The Compensation Committee shall determine the amount
of the Executive’s LTI award, if any, based upon the existing Management Compensation Plan. 
  

	 	d.	Employment Agreement Stock Options 

 In further
consideration of this Agreement and for the Executive’s obligations hereunder, the Executive shall be awarded a stock option grant as of the date this Agreement is fully executed (the “Effective Date”), with respect to 25,000 shares
(the “Sign-on Options”) of the Company’s common stock, par value $.01 (the “Common Stock”), vesting one-twelfth on the date the Executive signs this Agreement, and one-twelfth each succeeding month until March 31, 2008,
at the fair market value of the Common Stock at the close of business on the Effective Date. The Sign-on Options shall be granted pursuant to, and to the extent not contrary to the terms of this Agreement, shall be exercisable consistent with the
terms of the Company’s Stock Incentive Plan dated March 10, 2000, as amended April 6, 2004 (or comparable program if amended after the commencement of the Term of this Agreement) (the “Stock Option Plan”). 
  

	 	e.	Benefits 

 The Executive shall be eligible for
participation in the same welfare benefit plans, practices, policies and programs provided by the Company to senior executive officers of the Company, including but not limited to, health insurance, 401(k), medical, sick leave, sick pay, holidays,
long-term disability insurance and life insurance. The Executive shall be entitled to not less than three work weeks (15 work days) of paid vacation for each year of the Term, which vacation days shall accrue and become vested on the first day of
each year of the Term. 
  

 2 

	 	f.	Expenses 

 The Executive shall be reimbursed for all
reasonable business expenses incurred in the performance of his duties pursuant to this Agreement (including, without limitation, business travel related expenses) to the extent such expenses are substantiated and are consistent with the general
policies of the Company and its subsidiaries relating to the reimbursement of expenses of senior executive officers. 
  

	3.	Termination 

  

	 	a.	Termination by the Company for Cause 

 The Company
shall have the right to terminate the Executive for Cause (as such term is hereinafter defined) at any time during this Agreement. For purposes of this Agreement, “Cause” means any act or any failure to act on the part of the Executive
which constitutes: (i) the willful and knowing or negligent failure or refusal of the Executive to perform his duties under this Agreement or to follow the reasonable directions of the Company’s Chief Executive Officer; (ii) a breach
by the Executive of his fiduciary duty to the Company; (iii) misfeasance or malfeasance by the Executive in connection with the performance of his duties under this Agreement that has a demonstrably negative impact on the Company; (iv) the
Executive’s commission of an act of fraud or embezzlement with regard to the Company; or (v) the conviction of the Executive for, or a plea of guilty or nolo contendere to a criminal act which is a felony (other than as a result of
vicarious liability or a routine traffic violation). 
 In the event thereof, the Executive shall not be entitled to severance pay, or other
compensation or benefits, except accrued and unpaid base salary and benefits which the Executive accrued prior to the effective date of termination pursuant to any applicable benefit plan, earned but unused vacation for that year and unreimbursed
business-related expenses in accordance with Company policy. Sign-on Options, other stock options, shares of restricted stock, performance awards, stock appreciation rights, and LTI awards granted to Executive by the Company through the date of
termination shall be treated in accordance with the applicable plans and policies of the Company. 
  

	 	b.	Termination At or After Change in Control 

 In the
event the Executive’s employment is terminated upon or within one (1) year after a Change in Control defined in subparagraph 3(c) below, or prior to the Change in Control if the Executive’s termination, demotion or relocation was
either a condition of the Change in Control or was at the request of any person related to the Change in Control, and such termination was initiated by the Company without cause or by the Executive due to being requested to accept without cause a
demotion or relocation: 
 (i) The Company shall pay to the Executive any earned and accrued but unpaid installment of Base Salary through the
date of termination, at the rate in 

  

 3 

 
effect on the date of termination, or if greater, on the date immediately preceding the date that a Change in Control occurs, and all other unpaid amounts to
which the Executive is entitled as of the date of termination under any compensation plan or program of the Company, including, without limitation, all accrued vacation time. Sign-on Options, other stock options, shares of restricted stock,
performance awards, stock appreciation rights, and LTI awards granted to Executive by the Company through the date of termination shall be treated in accordance with the applicable plans and policies of the Company. All outstanding stock options
shall vest upon termination. 
 (ii) In lieu of any further Base Salary, bonus payments and benefits to the Executive for periods subsequent
to the date of termination, the Company shall pay as liquidated damages to the Executive, an amount equal to twelve (12) months of the Executive’s annual Base Salary at the rate in effect as of the date of termination, or if greater, on
the date immediately preceding the date that a Change in Control occurs. 
  

	 	c.	Change in Control 

 For the purposes of this
Agreement, a Change in Control shall be deemed to occur when and if, during the Term: 
 (i) any person (as such term is used in Sections
13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any affiliate or associate as defined in Rule 12(b)-2 under the Exchange Act of such person, other than the Company, any trustee or other
fiduciary holding securities under an employee benefit plan of the Company, or any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company)
becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 30% or more of the combined voting power of the Company’s then outstanding securities;

 (ii) individuals who, as of the date hereof, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at
least a majority of the Board, provided that any person becoming a director subsequent to the date hereof whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at least a majority of the directors
then comprising the Incumbent Board shall be, for purposes of this Agreement, considered as though such person were a member of the Incumbent Board; 
 (iii) the stockholders of the Company (A) approve a definitive agreement to merge or consolidate the Company with or into another corporation or other enterprise in which the holders of outstanding stock of the
Company entitled to vote in elections of directors immediately before such merger or consolidation hold less than 50% of the voting power of the survivor of such merger or consolidation or its parent, or (B) approve a plan of liquidation; or

  

 4 

 (iv) at least 80% of the Company’s assets are sold or transferred to another corporation or other
enterprise that is not a subsidiary, direct or indirect, or other affiliate of the Company. 
 (v) The Stockholders of the Company have
approved a plan of a complete liquidation or dissolution of the Company. 
  

	 	d.	Termination by the Company Without Cause 

 In the
event the Executive’s employment is terminated by the Company without Cause, other than as a result of a Change in Control as described in 3(b) and 3(c) or pursuant to a Termination Notice, the Company shall pay to the Executive any earned and
accrued but unpaid installment of Base Salary through the date of termination, at the rate in effect on the date of termination, and all other unpaid amounts to which the Executive is entitled as of the date of termination under any compensation
plan or program of the Company, including, without limitation, all accrued vacation time. Sign-on Options, other stock options, shares of restricted stock, performance awards, stock appreciation rights, and LTI awards granted to Executive by the
Company through the date of termination shall be treated in accordance with the applicable plans and policies of the Company. 
 In lieu of
any further Base Salary, bonus payments and benefits to the Executive for periods subsequent to the date of termination, the Company shall pay as liquidated damages to the Executive, an amount equal to three (3) months of the Executive’s
annual Base Salary at the rate in effect as of the date of termination. 
  

	 	e.	Expiration of the Term Pursuant to a Termination Notice by the Executive or the Company  

 If the Executive’s employment with the Company terminates at the end of the Term pursuant to a Termination Notice by the Executive or the Company,
the Company shall have no further obligation to the Executive under this Agreement, except accrued and unpaid base salary and benefits which the Executive accrued prior to the effective date of termination, i.e. the end of the term, pursuant to any
applicable benefit plan, earned but unused vacation for that year and unreimbursed business-related expenses in accordance with Company policy. Sign-on Options, other stock options, shares of restricted stock, performance awards, stock appreciation
rights, and LTI awards granted to Executive by the Company through the date of termination shall be treated in accordance with the applicable plans and policies of the Company. 
  

	 	f.	Automatic Termination Due To Death or Disability 

 If the Executive dies or suffers any Disability (as defined below) his employment pursuant to this Agreement shall automatically terminate on the date of his death or 

  

 5 

 
Date of Disability (as defined below), as the case may be. For purposes of this Agreement, the term “Disability” shall mean the inability of the
Executive to perform his duties, with or without reasonable accommodations, under this Agreement because of physical or mental illness or incapacity for a period of 90 consecutive days. For purposes of this Agreement, the term “Date of
Disability” shall be the 91st day of such Disability. 
 The Company shall have no further obligation to the Executive or the
Executive’s estate under this Agreement, except accrued and unpaid base salary and benefits which the Executive accrued prior to the effective date of termination pursuant to any applicable benefit plan, earned but unused vacation for that year
and unreimbursed business-related expenses in accordance with Company policy. Sign-on Options, other stock options, shares of restricted stock, performance awards, stock appreciation rights, and LTI awards granted to Executive by the Company through
the date of termination shall be treated in accordance with the applicable plans and policies of the Company. 
  

	4.	Discoveries and Works 

 The Executive agrees
that if at any time during the Term he, either independently or with others, makes, conceives, discovers, develops, or reduces to practice any invention, modification, discovery, design, development, improvement, process, program, work of
authorship, documentation, formula, data, technique, secret or intellectual property right whatsoever, including any television or film production, program, script or screen play, or any interest therein (whether or not patentable or registrable
under copyright or similar statutes or subject to analogous protection) (hereinafter referred to as “intellectual property rights”), not already in the public domain or previously known by the Executive that (a) relates to the
business of the Company or any affiliate of the Company, or any of the products or services being developed, manufactured, marketed or sold by the Company or any affiliate or which may be used in relation therewith; (b) results from tasks
assigned by the Company; or (c) results from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company or any affiliate, such intellectual property rights shall become the sole and
absolute property of the Company and its assigns. 
  

	5.	Confidentiality and Non-Competition Covenants 

  

	 	a.	Confidentiality 

 The Executive acknowledges that,
during the Term, the Executive may receive special training and/or may be given access to or may become acquainted with Confidential Information and Trade Secrets (as hereinafter defined) of the Company. As used in this Section 5, “Confidential
Information and Trade Secrets” of the Company means all trade practices, business plans, price lists, supplier lists, customer lists, marketing plans, financial information, software and all other compilations of information which relate to the
business of the Company, or to any of its affiliates, customers or suppliers, and which have not been disclosed by the Company to the public, or which are not otherwise generally available to the public. 
  

 6 

 The Executive acknowledges that the Confidential Information and Trade Secrets of the Company, as such
may exist from time to time, are valuable, confidential, special and unique assets of the Company and its affiliates, expensive to produce and maintain and essential for the profitable operation of their respective businesses. The Executive agrees
that, during the course of his employment with the Company, or at any time thereafter, he shall not, directly or indirectly, communicate, disclose or divulge to any Person (as hereinafter defined), or use for his benefit or the benefit of any
Person, in any manner, any Confidential Information or Trade Secrets of the Company or its affiliates acquired during his employment with the Company or any other confidential information concerning the conduct and details of the businesses of the
Company and its affiliates except in the course of performing his duties hereunder or with the Company’s express written consent; provided, however, that the restrictions above shall not apply to that part of the Confidential Information and
Trade Secrets that is or becomes generally available to the public other than as a result of an improper disclosure by the Executive or is available, or becomes available, to the Executive on a non-confidential basis, but only if the source of such
information is not to the Executive’s knowledge prohibited from transmitting the information to the Executive by a contractual, legal, fiduciary, or other obligation or that the Executive is required to disclose such Confidential Information
and Trade Secrets by applicable law, regulation or legal process. 
 All documents relating to the businesses of the Company and its
affiliates including, without limitation, Confidential Information and Trade Secrets of the Company, whether prepared by the Executive or otherwise coming into the Executive’s possession, are the exclusive property of the Company and such
respective affiliates, and must not be removed from the premises of the Company, except as required in the course of the Executive’s employment with the Company. The Executive shall return all such documents (including any copies thereof) to
the Company when the Executive ceases to be employed by the Company, provided the Company requests so in writing anytime during the Term of this Agreement and/or any Additional Employment Term or five (5) days after the termination of this
Agreement or upon the earlier request of the Company or the Board. 
  

	 	b.	Non-Competition 

 During the Term and for a period
of twelve (12) months following the termination of the Executive’s employment under this Agreement for any reason other than disability or death, the Executive shall not, except with the Company’s express prior written consent or in
the proper course of his employment with the Company, directly or indirectly, in any capacity, for the benefit of any Person (including the Executive): 
 (i) Become employed by, own, operate, manage, direct, invest in, or otherwise, directly or indirectly, engage in, or be employed by any Person, which is a 

  

 7 

 
Direct Competitor (as defined below) of the Company, its affiliates, or any of its respective businesses; provided the foregoing does not apply to an
affiliate of such Direct Competitor which does not itself compete with the Company and, in connection therewith the Executive may own equity in such non-competing affiliates. 
 (ii) Solicit, service, divert, take away, or contact any customer or client of the Company, or any of its affiliates, to provide or promote services then
provided by the Company, or any of its affiliates cord blood preservation and/or storage facility industry. 
 (iii) Induce or attempt to
induce any employee of the Company or its subsidiaries to stop working for the Company, or any of its affiliates, or to work for any competitor of the Company , or any of its affiliates; provided that the foregoing shall not be violated by general
advertising not targeted at Company employees nor by serving as a reference for an employee with regard to an entity with which the Executive is not affiliated. 
  

	 	c.	Definitions of Person and Direct Competitor 

 For
purposes of this Agreement, the term “Person” means any individual (except the Executive’s Assistant at the time of his termination), partnership, corporation, trust and/or any other entity of any nature whatsoever. A “Direct
Competitor” means any Person that operates or manages a cord blood preservation and/or storage facility (either existing as of the date of this Agreement or created or launched during the Term in the territories in which the Company operated
during the Term. However, “Direct Competitor” shall not mean any Person that operates or manages a Public Cord Blood Bank. A “Public Cord Blood Bank” means a cord blood preservation and/or storage facility which accepts cord
blood donations to be used by anyone in need of said cord blood. 
  

	6.	Reliance 

 The Executive acknowledges that
his compliance with the provisions of Section 5 of this Agreement (hereinafter referred to as the “Restrictive Covenants’) is a material part of the consideration bargained for by the Company under this Agreement. The Executive agrees to
be bound by the provisions of Section 5 of this Agreement to the maximum extent permitted by law, it being the intent and spirit of the parties to this Agreement that the provisions of Section 5 of this Agreement shall be enforceable. However, the
parties to this Agreement further agree that if any portion of the Restrictive Covenants or their application is construed to be invalid or unenforceable, then the other portions thereof and their application shall not be affected thereby and shall
be enforceable. If the Restrictive Covenants shall for any reason be held to be excessively broad as to duration, geographic scope, property, subject or similar factor, then the court making such determination shall have the power to reduce or limit
such duration, geographic scope, property, subject or similar factors so as to be enforceable to the maximum extent compatible with applicable law, and the Restrictive Covenants shall then be enforceable in its reduced or limited form. 

 

 8 

	7.	Equitable Relief and Enforcement 

 The
Executive further acknowledges that any breach by him of the Restrictive Covenants will result in irreparable injury to the Company and its affiliates for which money damages could not adequately compensate the Company or such affiliates. In the
event of any such breach, the Company shall be entitled, in addition to all other rights and remedies which it may have at law or in equity, to have an injunction issued by any competent court enjoining and restraining the Executive from continuing
such breach. 
  

	8.	Indemnification 

 The Company hereby agrees
to indemnify the Executive and hold him harmless to the fullest extent permitted by applicable law against and in respect to any and all actions, suits, proceedings, claims, demands, judgments, costs, expenses (including reasonable attorney’s
fees), losses, and damages resulting from the Executive’s good faith performance of his duties and obligations with the Company. This provision is in addition to any other rights of indemnification the Executive may have. This provision shall
in all events survive any termination of this Agreement. 
  

	9.	Liability Insurance 

 The Company shall cover
the Executive under directors and officers liability insurance both during and, while potential liability exists, after the Term in the same amount and to the same extent as the Company covers its other senior executive officers and directors. This
provision shall in all events survive any termination of this Agreement. 
  

	10.	Miscellaneous 

  

	 	a.	Entire Agreement 

 This Agreement constitutes the
entire agreement between the parties to this Agreement with respect to the subject matter of this Agreement and supersedes all prior negotiations, understandings, agreements, arrangements and understandings, both oral and written, between the
parties to this Agreement with respect to the Executive’s employment during the Term. This Agreement shall not be construed as affecting in any way the shares of restricted stock, performance awards, stock appreciation rights and stock options
provided to the Executive by the Company prior to the date of this Agreement other than as expressly provided herein. 
  

 9 

	 	b.	Amendment; Waivers; Headings 

 This Agreement may
not be amended or modified in any respect, except by the mutual written agreement of the parties to this Agreement. The waiver by any of the parties to this Agreement of any other party’s prompt and complete performance, or breach or violation,
of any of the provisions of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or violation, and the waiver by any of the parties to this Agreement to exercise any right or remedy which it may possess under this
Agreement shall not operate nor be construed as a bar to the exercise of such right or remedy by such party upon the occurrence of any subsequent breach or violation. Descriptive headings contained in this Agreement are for convenience only and
shall not control or affect the meaning or construction of any provision of this Agreement. Notwithstanding anything in this Agreement to the contrary, the provisions of Sections 4, 5, 6, 7, 8 and 9 of this Agreement shall survive the termination of
the Executive’s employment under this Agreement, however caused, and the termination of this Agreement. 
  

	 	c.	Counterparts 

 This Agreement may be executed in any
number of counterparts and by the separate Parties hereto in separate counterparts, each of which shall be deemed to be one and the same instrument. 
  

	 	d.	Notices 

 All notices, requests, demands,
instructions, consents or other communications required or permitted to be given under this Agreement shall be in writing and shall be deemed to have been duly given if and when (a) delivered personally, (b) transmitted by facsimile,
prepaid telegram or telex, (c) mailed by first class certified mail, return receipt requested, postage prepaid, or (d) sent by an internationally recognized express courier service, postage or delivery charges prepaid, to the Parties at
their respective addresses set forth in the first paragraph of this Agreement or to such other addresses as the parties may give notice in accordance with the terms of this Agreement. 
  

	 	e.	Successors and Assigns 

 This Agreement shall be
binding upon and shall inure to the benefit of the Parties to this Agreement and their respective personal representatives, heirs, successors and assigns. 
  

	 	f.	Applicable Law; Arbitration as Exclusive Remedy 

 This Agreement shall be governed by and construed in accordance with the laws of the State of Florida. All controversies or claims arising out of or relating to paragraph I through 3 of this Agreement or the breach thereof, or the
termination thereof, shall be resolved by arbitration administered by the American Arbitration Association under its National Rules for the Resolution of Employment Disputes. The 

  

 10 

 
award rendered in any arbitration proceeding under this section shall be final and binding. Judgment upon the award rendered by the arbitrator(s) may be
entered by a court of competent jurisdiction. Any claim or controversy not submitted to arbitration in accordance with this section shall be considered waived, and, therefore, no arbitration panel or tribunal or court shall have the power to rule or
make any award on such claims or controversy. Any such arbitration shall be conducted in Tampa, Florida. The prevailing party in such arbitration proceeding shall be entitled to recover reasonable expenses, including attorneys fees and costs.

 The parties agree to submit all controversies or claims arising out of or relating to paragraphs 4 through 7 to the exclusive jurisdiction
of the courts of the State of Florida. The parties further agree that the only and proper venue for any action upon any alleged breach of any provision or obligation under this Agreement shall be Hillsborough County, Florida. 
 IN WITNESS WHEREOF, the parties to this Agreement have placed their hands as of the day and year first above written. 
  

							
	 	  	Cryo-Cell International, Inc.
			
	 /S/ ROBERT DOLL
	  	By:	 	 /S/ MERCEDES WALTON

	Robert Doll	  	Name:	 	Mercedes Walton
		 		  	Title:	 	Chief Executive Officer
	Date:	 	 APRIL 18, 2007
	  	Date:	 	 APRIL 18, 2007

  

 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00126-of-00352.parquet"}]]